PRESENTATION

Lower back pain is the leading cause of non-fatal health loss worldwide and is drastically impacting people’s quality of life. Disorders of the spine such as degenerative disc disease, narrowing of the spinal canal (stenosis) or spondylolisthesis (slipped vertebra), may result in severe back and leg pain.

In the US alone nearly 2 million people need to undergo surgery each year. Spinal fusion is one of the most common type of surgery performed and consists of connecting two or more vertebrae to improve stability, correct a deformity or reduce pain. This procedure typically involves placing pedicle screws and short rods in the treated segment for spinal stability. It is a complex and time-consuming procedure associated with high risks and long recovery time.

With the current high entry barrier only a fraction of the patients get access to the care they need. InnoSpina is on a mission to change that.

Image

InnoSpina is leveraging the design freedom offered by metal Additive Manufacturing (3D Printing) to develop innovative solutions and optimal inner structure favoring bone integration.

OUR TEAM

Gwenael Hannema

DEVELOPPEMENT & EXECUTION

Dr. Jacques Samani

SURGERY

Nicole Beuchat

MANUFACTURING

DEVELOPMENT PROCESS

  • User needs

  • Development of novel implants & surgical instruments

  • Design freeze - V&V - bench tests

  • Preclinical & clinical validations

  • RA approval / Surgery

User needs

Development of novel implants & surgical instruments

Design freeze - V&V - bench tests

Preclinical & clinical validations

RA approval / Surgery

OUR VISION

At InnoSpina, we want to provide safe and intuitive guiding instruments together with novel implants empowering spine surgeons and interventional pain management specialists in their daily procedures. We design and develop new motion preserving and fusion technologies for disorders of the spine enabling the practitioner to treat chronic back pain in less than 30 minutes.

We are currently developing flagship products targeting different stage of the LSS disease. We have successfully conducted pre-clinical validations that confirmed the safety and effectiveness of our unique guiding instruments and we recently gained traction among spine surgeons.

AWARDS & SUPPORTERS

At InnoSpina, we are highly grateful for all the support received from our partners.

This project has received funding from the Swiss Innovation Agency (Innosuisse) and the Economic Promotion from Canton Jura.